Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 31, 2009
Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: the SPIRIT III 4.0 mm registryPaul C Gordon, Robert J Applegate, James B Hermiller, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2012
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trialsJames B Hermiller, Krishnankutty Sudhir, Robert J Applegate, et al.The New England Journal of Medicine|May 7, 2010
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery diseaseGregg W Stone, Ali Rizvi, William Newman, et al.JACC. Cardiovascular Interventions|September 21, 2013
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)George D Dangas, Patrick W Serruys, Dean J Kereiakes, et al.Circulation. Cardiovascular Interventions|March 23, 2012
Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitionsM Hassan Pervaiz, Poornima Sood, Krishnankutty Sudhir, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 17, 2009
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trialAlexandra J Lansky, Vivian G Ng, Halil Mutlu, et al.European Heart Journal|September 3, 2015
A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB JapanTakeshi Kimura, Ken Kozuma, Kengo Tanabe, et al.Pageof 2